39.00NOK+2.36%Mkt Cap: 610.62M NOKP/E: —Last update: 2026-05-13
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemi…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)10.08
PEG—
P/B2.97
P/S3.46
EV/EBITDA18.45
EV/Revenue2.98
EPS (TTM)-0.96
EPS (Forward)3.92
Cash Flow & Leverage
FCF Yield3.57%
FCF Margin12.35%
Operating CF42.59M NOK
CapEx (TTM)10.76M NOK
Net Debt/EBITDA-2.91
Net Debt-82.94M NOK
Technical
SMA 5040.33 (-3.3%)
SMA 20051.09 (-23.7%)
Beta0.43
S&P 52W Chg24.23%
Avg Vol (30d)11.99K
Avg Vol (10d)14.33K
Technical Indicators
RSI (14)43.6
MACD-0.6804
MACD Signal-0.0757
MACD Hist.-0.6047
BB Upper47.34 NOK
BB Middle42.16 NOK
BB Lower36.98 NOK
BB Width24.57%
ATR (14)2.269 NOK
Vol Ratio (20d)0.54x
52W Range
36.1010% of range65.80
52W High65.80 NOK
52W Low36.10 NOK
Profitability
Gross Margin55.64%
EBITDA Margin16.16%
Profit Margin7.51%
Oper. Margin17.49%
ROE6.47%
ROA5.13%
Revenue Growth9.30%
Earnings Growth-89.20%
Balance Sheet
Debt/Equity0.11
Current Ratio5.40
Quick Ratio3.81
Book Value/Sh13.29 NOK
Cash/Share6.869 NOK
Dividends
Fwd Div Rate0.6000 NOK
Trail. Div Rate0.0000 NOK
Div. Yield1.52%
5Y Avg Yield—
Payout Ratio46.51%
Ex-Div DateMay 6, 2026
Pay Date—
Ownership
Shares Out.15.46M
Float11.67M
Insiders44.62%
Institutions39.56%
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)60.00 NOK
Target Range60.00 NOK – 60.00 NOK
# Analysts1
Company
Market Cap610.62M NOK
Enterprise Value526.24M NOK
Revenue (TTM)176.50M NOK
Gross Profit98.20M NOK
Net Income (TTM)13.26M NOK
Revenue/Share11.45 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees63
Last Price39.00 NOK
CountryNO
SectorHealthcare
IndustryMedical Devices
ISIN—